openPR Logo
Press release

Research Antibodies Market 2027 by Current Scenario, Key Segments and Top Profiles Forecast - Agilent Technologies, BD, Bio-Rad Laboratories, Cell Signaling Technology, F. Hoffmann-La Roche, GenScript, Merck KGaA

12-12-2018 07:26 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: The Insight Partners

The Insight Partners

The Insight Partners

A comprehensive analysis on “Research Antibodies Market” is the latest industry dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. This report includes potential opportunities in the cell harvesting industry at the global and regional levels.

Global Research Antibodies Market Analysis and Forecasts to 2027

Antibodies are an essential component in research activities as they are used as molecular tags for specific labeling and detection. Antibodies are used as tools by the researchers to identify the molecules that cannot be seen by the naked eye. Various procedures such as flow cytometry, western blot, enzyme-linked immunosorbent assay (ELISA), and immunohistochemistry (IHC) require research antibodies in order to draw the needed results. In recent years, antibodies are also being used for diagnostic as well as therapeutic purposes.

Key Players operating in the research antibodies market include, Abcam plc. Agilent Technologies, Inc., BD, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., F. Hoffmann-La Roche Ltd, GenScript, Merck KGaA, PerkinElmer Inc., and Thermo Fisher Scientific Inc. among others.

Get Sample Copy at https://www.theinsightpartners.com/sample/TIPBT00002599/

The Research Antibodies Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

The "Global Research Antibodies Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by product, technology, application, end user, and geography. The global research antibodies market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global research antibodies market is segmented on the basis of product, technology, application and end user. On the basis of product, the research antibodies market is segmented as, antibodies and reagents. The segment of antibodies is further segmented as, primary antibodies and secondary antibodies. Based on technology, the market is segmented as, western blotting, flow cytometry, enzyme-linked immunosorbent assay, immunoprecipitation, immunohistochemistry, immunofluorescence, and other technologies.
On the basis of application, the market is classified as, stem cell, oncology, immunology, infectious diseases, neurobiology, and other applications. The research antibodies market is classified based on end user as, academic & research institutes, pharmaceutical & biotechnological companies and contract research organizations.

Browse Complete Report at https://www.theinsightpartners.com/reports/research-antibodies-market

The Research Antibodies Market report is a combination of qualitative as well as quantitative analysis which can be broken down into 40% and 60% respectively. Market estimation and forecasts are presented in the report for the overall global market from 2018 – 2027, considering 2018 as the base year and 2019 – 2027 forecast period. Global estimation is further broken down by segments and geographies such as North America, Europe, Asia-Pacific, Middle East & Africa and South America covering major 16 countries across the mentioned regions. The qualitative contents for geographical analysis will cover market trends in each region and country which includes highlights of the key players operating in the respective region/country, PEST analysis of each region which includes political, economic, social and technological factors influencing the growth of the market.

North America is expected to contribute to the largest share in the research antibodies market in the coming years, due to the presence of pharmaceutical and research organizations along with rising emphasis on research activities. During the forecast period, Asia Pacific is anticipated to witness significant growth in the market, owing to rising government funds and initiatives for conducting research activities for drug discover and therapeutics.

Contact Information -
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Healthcare IT, Biotechnology and Medical Device industries.

533, 5th Floor,
Amanora Chambers, East Block, Amanora Township,
Kharadi Road, Hadapsar, Pune-411028

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Research Antibodies Market 2027 by Current Scenario, Key Segments and Top Profiles Forecast - Agilent Technologies, BD, Bio-Rad Laboratories, Cell Signaling Technology, F. Hoffmann-La Roche, GenScript, Merck KGaA here

News-ID: 1433966 • Views:

More Releases from The Insight Partners

Freight and logistics - Obtain PDF Sample Copy
Freight and logistics form the backbone of global trade, ensuring the smooth movement of goods from origin to destination. Freight refers to the transportation of cargo by road, rail, air, or sea, while logistics covers the broader process of planning, managing, and coordinating storage, inventory, and delivery. Together, they enable businesses to optimize supply chains, reduce costs, and improve customer satisfaction. Download PDF - https://www.theinsightpartners.com/sample/TIPRE00010519?utm_source=OpenPR&utm_medium=10309
Non-Resilient Flooring Market on a Growth Trajectory, Spurred by the Construction Sector and Sustainability Efforts
Non-Resilient Flooring Market on a Growth Trajectory, Spurred by the Constructio …
New York, US - September 9, 2025- A new report from The Insight Partners, titled "Non-Resilient Flooring Market - Global Analysis and Forecast," reveals that the global market for non-resilient flooring is embarking on a robust growth trajectory. The report posits that the market's expansion is being fueled by a surge in demand for enduring flooring solutions, escalating construction and renovation activities worldwide, and a pivotal shift toward eco-friendly materials. Check
Opto Isolator Market Surges Towards 2031
Opto Isolator Market Surges Towards 2031
A recent report by The Insight Partners, titled "Opto Isolator Market Share, Size, Trends, and Forecast by 2031," projects significant growth for the global opto isolator market. The report, released on September 8, 2025, from New York, U.S., provides an in-depth analysis of the current market landscape, key drivers, challenges, and future opportunities. It forecasts steady expansion in market size, share, and innovation up to 2031, offering valuable insights for
Non-Resilient Flooring Market on a Growth Trajectory, Spurred by the Construction Sector and Sustainability Efforts
Non-Resilient Flooring Market on a Growth Trajectory, Spurred by the Constructio …
New York, US - September 9, 2025- A new report from The Insight Partners, titled "Non-Resilient Flooring Market - Global Analysis and Forecast," reveals that the global market for non-resilient flooring is embarking on a robust growth trajectory. The report posits that the market's expansion is being fueled by a surge in demand for enduring flooring solutions, escalating construction and renovation activities worldwide, and a pivotal shift toward eco-friendly materials. Check

All 5 Releases


More Releases for Antibodies

Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Arthritis Monoclonal Antibodies Market Report 2024 - Arthritis Monoclonal Antibo …
"The Business Research Company recently released a comprehensive report on the Global Arthritis Monoclonal Antibodies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The arthritis monoclonal antibodies
Global Multispecific Antibodies Market Size Antibodies Sales Forecast 2029
Global Multispecific Antibodies Market, Drug Sales, Price & Clinical Trials Insight 2029 Report Highlights: • Global & Regional Market Analysis • Global Multispecific Antibodies Market Opportunity: > USD 40 Billion • Global Multispecific Antibodies Market Sales In 2023: > USD 8 Billion • Number Of Approved Multispecific Antibodies: 14 • Approved Antibodies Global, Regional, Annual & Quarterly Sales Insight • Approved Antibodies Dosage & Pricing Insight • Number Of Multispecific Antibodies: In Clinical Trials: > 900 • Comprehensive Insight On All Antibodies In Clinical Trials By
Global Bispecific Antibody Market Size Bispecific Antibodies Clinical Trials FDA …
Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights: • Bispecific Antibodies Development Proprietary Platforms Insight: > 30 Platforms • Global Bispecific Antibodies Market Size Yearly and Quarterly Sales (2018 till 2023) • Global Bispecific Antibodies Market Size 2023: > USD 8 Billion • Global Bispecific Antibodies Market Forecast Till 2029 • Approved Bispecific Antibodies Yearly and Quarterly Sales (2018 till 2023) • Approved Bispecific Antibodies Regional Sales (2018 till 2023) • Clinical and Commercial Insight On Approved
Emergence of Tetravalent Antibodies
The emergence of tetravalent antibodies represents a significant advancement in the field of therapeutic antibodies, offering new possibilities for treating complex diseases such as cancer, infectious diseases, and autoimmune disorders. These innovative molecules, capable of binding to four antigens or epitopes simultaneously, provide enhanced specificity, efficacy, and versatility, addressing the limitations of traditional monoclonal and even bispecific antibodies. Download Bispecific, Trispecific and Tetraspecific Antibodies Report: https://www.kuickresearch.com/ccformF.php?t=1721642510 Tetravalent antibodies are designed to engage